Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection

被引:84
作者
Biffi, R. [1 ]
Botteri, E. [2 ]
Cenciarelli, S. [1 ]
Luca, F. [1 ]
Pozzi, S. [1 ]
Valvo, M. [1 ]
Sonzogni, A. [3 ]
Chiappa, A. [4 ]
Ghezzi, T. Leal [1 ]
Rotmensz, N. [2 ]
Bagnardi, V. [2 ,5 ]
Andreoni, B. [4 ]
机构
[1] European Inst Oncol, Div Abdomino Pelv Surg, I-20141 Milan, Italy
[2] European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy
[3] European Inst Oncol, Div Pathol, I-20141 Milan, Italy
[4] European Inst Oncol, Div Gen & Laparoscop Surg, I-20141 Milan, Italy
[5] Univ Milano Bicocca, Dept Stat, Milan, Italy
来源
EJSO | 2011年 / 37卷 / 04期
关键词
Gastric cancer; Gastrectomy; Extended lymph node dissection; TNM classification; Preoperative chemotherapy; ASSISTED GASTRECTOMY; LYMPHADENECTOMY; D2; MORBIDITY; CARCINOMA; SURGERY; D1; MORTALITY; DISEASE; BENEFIT;
D O I
10.1016/j.ejso.2011.01.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study was designed to establish whether the number of lymph nodes removed has an effect on prognosis in patients with node-negative gastric cancer. Patients and Methods: We retrospectively analysed data of 114 consecutive patients who underwent gastrectomy and extended lymph node dissection for node-negative adenocarcinoma of the stomach between 2000 and 2005. Standard survival methods and restricted cubic spline multivariable Cox regression models were applied. Results: Median age was 63 years and 67 patients out of 114 (59%) were males. Median number of dissected LNs was 22 (range 2-73). Median follow-up was 76 months. Patients who had <= 15 nodes removed had significantly worse distant disease-free survival, disease-free survival and overall survival at multivariable analysis than other patients. The results did not change when pT1 and pT2-3 cancer patients were analysed separately. The risk of distant metastases decreased as the number of dissected lymph nodes increased (> 15). Conclusions: More extended lymph node resection offered survival benefit even in the subgroup of patients with early stage disease. Lymphadenectomy involving more than 15 lymph nodes should be performed for the treatment of node-negative gastric cancer. Synopsis: The impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer has not been established. This study suggests that more extended lymph node resection offers protection, as patients who had <= 15 nodes removed had significantly worse disease-free survival and overall survival at multivariate analysis than patients in whom > 15 nodes were removed. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:305 / 311
页数:7
相关论文
共 37 条
[1]   Assessment of Open Versus Laparoscopy-Assisted Gastrectomy in Lymph Node-Positive Early Gastric Cancer: A Retrospective Cohort Analysis [J].
An, Ji Yeong ;
Heo, Geon-Ung ;
Cheong, Jae-Ho ;
Hyung, Woo Jin ;
Choi, Seung Ho ;
Noh, Sung Hoon .
JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (01) :77-81
[2]   A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer Patients [J].
Baiocchi, Gian Luca ;
Tiberio, Guido A. ;
Minicozzi, Anna Maria ;
Morgagni, Paolo ;
Marrelli, Daniele ;
Bruno, Lorenzo ;
Rosa, Fausto ;
Marchet, Alberto ;
Coniglio, Arianna ;
Saragoni, Luca ;
Veltri, Marco ;
Pacelli, Fabio ;
Roviello, Franco ;
Nitti, Donato ;
Giulini, Stefano M. ;
De Manzoni, Giovanni .
ANNALS OF SURGERY, 2010, 252 (01) :70-73
[3]   Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: Low morbidity and mortality rates in a single center series of 250 patients [J].
Biffi, R ;
Chiappa, A ;
Luca, F ;
Pozzi, S ;
Lo Faso, F ;
Cenciarelli, S ;
Andreoni, B .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (05) :394-400
[4]   Case mix at the European Institute of Oncology: first report of the Tumour Registry, 2000-2002 [J].
Botteri, E. ;
Iodice, S. ;
Maisonneuve, P. ;
Alfieri, M. ;
Burzoni, N. ;
Manghi, L. ;
Martinetti, M. ;
Montanari, B. ;
Albertazzi, E. ;
Bazolli, B. ;
Rotmensz, N. .
ECANCERMEDICALSCIENCE, 2009, 3
[5]   SURGICAL PATHOLOGICAL-STAGE MIGRATION CONFOUNDS COMPARISONS OF GASTRIC-CANCER SURVIVAL RATES BETWEEN JAPAN AND WESTERN COUNTRIES [J].
BUNT, AMG ;
HERMANS, J ;
SMIT, VTHBM ;
VANDEVELDE, CJH ;
FLEUREN, GJ ;
BRUIJN, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :19-25
[6]   Patient survival after D1 and D2 resections for gastric cancer:: long-term results of the MRC randomized surgical trial [J].
Cuschieri, A ;
Weeden, S ;
Fielding, J ;
Bancewicz, J ;
Craven, J ;
Joypaul, V ;
Sydes, M ;
Fayers, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1522-1530
[7]   Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial [J].
Degiuli, M ;
Sasako, M ;
Calgaro, M ;
Garino, M ;
Rebecchi, F ;
Mineccia, M ;
Scaglione, D ;
Andreone, D ;
Ponti, A ;
Calvo, F .
EJSO, 2004, 30 (03) :303-308
[8]   FLEXIBLE REGRESSION-MODELS WITH CUBIC-SPLINES [J].
DURRLEMAN, S ;
SIMON, R .
STATISTICS IN MEDICINE, 1989, 8 (05) :551-561
[9]   Gastric cancer: global pattern of the disease and an overview of environmental risk factors [J].
Forman, D. ;
Burley, V. J. .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (04) :633-649
[10]   Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial [J].
Hartgrink, HH ;
van de Velde, CJH ;
Putter, H ;
Bonenkamp, JJ ;
Kranenbarg, EK ;
Songun, I ;
Welvaart, K ;
van Krieken, JHJM ;
Meijer, S ;
Plukker, JTM ;
van Elk, PJ ;
Obertop, H ;
Gouma, DJ ;
van Lanschot, JJB ;
Taat, CW ;
de Graaf, PW ;
von Meyenfeldt, MF ;
Tilanus, H ;
Sasako, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2069-2077